Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003086 | Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer | terminated | Phase 1 / Phase 2 | 12 | Louisiana State University Health Sciences Center ShreveportOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT02624700 | 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer | terminated | Phase 2 | 13 | Virginia Commonwealth UniversityOTHER | 1 | Jul 14, 2020 |
| clinicaltrials |
| NCT02462200 | Shave Margins in Breast Conservation Therapy(SMART) | terminated | Phase 2 | 81 | Washington University School of MedicineOTHER | 1 | Jun 25, 2020 | clinicaltrials |
| NCT02202746 | A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer | terminated | Phase 2 | 178 | Clovis Oncology, Inc.INDUSTRY | 1 | Jun 23, 2020 | clinicaltrials |
| NCT01627067 | Exemestane-RAD001-Metformin | terminated | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 19, 2020 | clinicaltrials |
| NCT04149353 | PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo | terminated | N/A | 1 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT03343613 | A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors | terminated | Phase 1 | 60 | Eli Lilly and CompanyINDUSTRY | 6 | Jun 9, 2020 | clinicaltrials |
| NCT00090480 | Vaccine Treatment for Advanced Breast Cancer | terminated | Phase 1 / Phase 2 | 3 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT00739609 | IDO Inhibitor Study for Relapsed or Refractory Solid Tumors(D-1MT) | terminated | Phase 1 | 17 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT03050398 | A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib | terminated | Phase 3 | 8 | Novartis PharmaceuticalsINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT04066790 | Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer | terminated | Phase 2 | 12 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT01409811 | Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid | terminated | N/A | 9 | City of Hope Medical CenterOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT01532960 | Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer(Breast 41) | terminated | Phase 1 | 11 | Craig L Slingluff, JrOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT02615509 | Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography | terminated | N/A | 347 | Philips Digital Mammography Sweden ABINDUSTRY | 1 | May 8, 2020 | clinicaltrials |
| NCT00610467 | Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis | terminated | N/A | 2 | University of California, IrvineOTHER | 1 | Apr 20, 2020 | clinicaltrials |
| NCT02774681 | Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis | terminated | Phase 2 | 12 | Northwestern UniversityOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT01060345 | A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ | terminated | Phase 2 | 20 | University of ChicagoOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT02275871 | Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer | terminated | N/A | 44 | Beth Israel Deaconess Medical CenterOTHER | 1 | Mar 16, 2020 | clinicaltrials |
| NCT03763851 | Cannabis Oil and Radiation Therapy for the Management of Pain | terminated | Phase 2 | 100 | Tetra Bio-PharmaINDUSTRY | 1 | Mar 12, 2020 | clinicaltrials |
| NCT02532400 | Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients(COMPETE) | terminated | Phase 3 | 21 | Ruijin HospitalOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT03524248 | Development of Real-time Image-guided Radiotherapy | terminated | N/A | 159 | Fox Chase Cancer CenterOTHER | 1 | Mar 2, 2020 | clinicaltrials |
| NCT01900730 | Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter | terminated | Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT01392352 | HYPAZ: Hypertension Induced by Pazopanib(HYPAZ) | terminated | Phase 2 | 31 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT02576665 | A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) | terminated | Phase 1 | 21 | Tocagen Inc.INDUSTRY | 1 | Feb 7, 2020 | clinicaltrials |
| NCT02809846 | Quell Opioid Reduction and Pain Relief in Patients With Cancer | terminated | N/A | 33 | Scripps Translational Science InstituteOTHER | 1 | Jan 21, 2020 | clinicaltrials |
| NCT00616122 | Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | University of California, San FranciscoOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT02003092 | RX-5902 Treatment of Subjects With Triple Negative Breast Cancer | terminated | Phase 1 / Phase 2 | 18 | Rexahn Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 6, 2020 | clinicaltrials |
| NCT00738998 | Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors | terminated | N/A | 102 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT01545648 | Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer | terminated | Phase 2 | 4 | Hope Rugo, MDOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT01624090 | Mithramycin for Lung, Esophagus, and Other Chest Cancers | terminated | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | Dec 30, 2019 | clinicaltrials |
| NCT01086696 | A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers | terminated | Early Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00923052 | The Natural History of Solid Organ Cancer Stem Cells (SOCSC) | terminated | — | 190 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00574236 | Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer | terminated | Phase 2 | 4 | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT01902823 | Effect of Cancer Nurse Navigators on Patient Outcomes | terminated | Phase 2 / Phase 3 | 16 | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT03300843 | Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Dec 13, 2019 | clinicaltrials |
| NCT02538471 | LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer | terminated | Phase 2 | 3 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT01374685 | Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans | terminated | — | 8 | National Human Genome Research Institute (NHGRI)NIH | 1 | Dec 3, 2019 | clinicaltrials |
| NCT00456846 | First Line Therapy for Patients With Metastatic Breast Cancer | terminated | Phase 2 | 123 | CelgeneINDUSTRY | 1 | Nov 22, 2019 | clinicaltrials |
| NCT01952054 | Denosumab for Breast Cancer With Bone Mets | terminated | Phase 2 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT00651716 | T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant | terminated | — | 150 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT00531271 | ABI-008 Trial in Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 85 | CelgeneINDUSTRY | 1 | Nov 14, 2019 | clinicaltrials |
| NCT00948285 | Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer(BSMART) | terminated | N/A | 194 | Texas Tech University Health Sciences CenterOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT01118975 | GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers | terminated | Phase 1 / Phase 2 | 12 | University of Maryland, BaltimoreOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT01881932 | Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232) | terminated | N/A | 19 | University of Maryland, BaltimoreOTHER | 1 | Nov 7, 2019 | clinicaltrials |
| NCT03655600 | Acupressure for Pain and Opioid Use Among Breast Cancer Patients(AcuPOP) | terminated | N/A | 8 | University of MichiganOTHER | 1 | Oct 25, 2019 | clinicaltrials |
| NCT02941835 | Preoperative Breast Irradiation(PROBI) | terminated | N/A | 4 | The Netherlands Cancer InstituteOTHER | 1 | Oct 22, 2019 | clinicaltrials |
| NCT02318901 | Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer(PembroMab) | terminated | Phase 1 / Phase 2 | 16 | Western Regional Medical CenterOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT02472353 | Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer | terminated | Phase 2 | 30 | Avera McKennan Hospital & University Health CenterOTHER | 1 | Oct 16, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jul 14, 2020source: clinicaltrials